Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kris Jacobs
Observed names:
Jacobs Kris,
Jacobs, Kris,
K Jacobs,
K. Jacobs
Institutions:
VIB-KU Leuven Center for Cancer Biology,
KU Leuven
Observed institutions:
Universitair Ziekenhuis Leuven,
Vlaams Instituut voor Biotechnologie,
VIB-KU Leuven Center for Cancer Biology,
KU Leuven
ORCID:
0009-0002-9733-4826
Observed ORCID:
0009-0002-9733-4826
OpenAlex ID:
A5091700240
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
2012
·
Kim De Keersmaecker
, Zeynep Kalender Atak
, et al.
·
Nature Genetics
·
475
PDF
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
2014
·
Sandrine Degryse
, Charles E. de Bock
, et al.
·
Blood
·
155
PDF
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
2017
·
S Degryse
, C E de Bock
, et al.
·
Leukemia
·
89
PDF
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
2019
·
Michael Broux
, Cristina Prieto
, et al.
·
Blood
·
57
PDF
Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
2018
·
S. Degryse
, C. E. de Bock
, et al.
·
Leukemia
·
55
PDF
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
2017
·
Jo-Anne van der Krogt
, Marlies Vanden Bempt
, et al.
·
Haematologica
·
42
PDF
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL
2017
·
Sandrine Degryse
, Simon Bornschein
, et al.
·
Blood
·
40
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
2021
·
Koen Debackere
, Lukas Marcelis
, et al.
·
Nature Communications
·
36
PDF
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
2019
·
Delphine Verbeke
, Olga Gielen
, et al.
·
HemaSphere
·
30
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia
2020
·
Delphine Verbeke
, Sofie Demeyer
, et al.
·
Clinical Cancer Research
·
27
PDF
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
2022
·
Marlies Vanden Bempt
, Koen Debackere
, et al.
·
Blood
·
24
JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
2019
·
Inge Govaerts
, Kris Jacobs
, et al.
·
HemaSphere
·
22
PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia
2021
·
Inge Govaerts
, Cristina Prieto
, et al.
·
Journal of Hematology & Oncology
·
21
PDF
Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling
2016
·
Sebastian K. Wandinger
, Idoya Lahortiga
, et al.
·
PLoS ONE
·
17
PDF
Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
2021
·
Inge Lodewijckx
, Nicole Mentens
, et al.
·
HemaSphere
·
10
Identification of novel FLT3 kinase inhibitors
2013
·
Daphnie Pauwels
, Hugo Klaassen
, et al.
·
European Journal of Medicinal Chemistry
·
8
Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia
2023
·
Charlien Vandersmissen
, Cristina Prieto
, et al.
·
Haematologica
·
5
PDF
Abstract 4800: Covalent Flt3-Cys828 inhibition represents a novel therapeutic approach for the treatment of Flt3-ITD and Flt3-D835 mutant acute myeloid leukemia
2016
·
Matthias Versele
, Burkhard Haefner
, et al.
·
Cancer Research
·
4
TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia
2025
·
Lukas Lauwereins
, Quentin Van Thillo
, et al.
·
Leukemia
·
3
JAK3 Mutants Transform Hematopoietic Cells through JAK1 Activation Causing T-Cell Acute Lymphoblastic Leukemia in a Bone Marrow Transplant Mouse Model
2014
·
Degryse Sandrine
, Charles E de Bock
, et al.
·
Blood
·
3
Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia
2024
·
Charlien Vandersmissen
, Sofie Demeyer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
3023 – Characterization of the Oncogenic Activity of Tlx1 and Tlx3 Transcription Complexes in T-all
2024
·
Alexandra Bacquelaine Veloso
, Lukas Lauwereins
, et al.
·
Experimental Hematology
PDF
Author Reply to Peer Reviews of Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia
2024
·
Charlien Vandersmissen
, Sofie Demeyer
, et al.
Dual targeting of EZH2 and Histone Deacetylases in hematological malignancies promotes transcriptional and metabolic deregulation leading to ferroptosis
2024
·
Alexandra Veloso
, Thomas Slegers
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Table 5 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia
2023
·
Delphine Verbeke
, Sofie Demeyer
, et al.
Show more works
View as search
Works count:
44
Citation count:
1,124
H-index:
14
I10-index:
15
Year
Topic
Type